Woronoff-Lemsi MC - Search Results

1

Cost Effectiveness of Cardioprotective Strategies in Patients with Aggressive Non-Hodgkin's Lymphoma.

Limat S, Demesmay K, Fagnoni P, Voillat L, Bernard Y, Deconinck E, Brion A, Arveux P, Cahn JY, Woronoff-Lemsi MC. Limat S, et al. Clin Drug Investig. 2005;25(11):719-29. doi: 10.2165/00044011-200525110-00005. Clin Drug Investig. 2005. PMID: 17532718

2

Cost effectiveness of high-dose chemotherapy with autologous stem cell support as initial treatment of aggressive non-Hodgkin's lymphoma.

Fagnoni P, Milpied N, Limat S, Deconinck E, Nerich V, Foussard C, Colombat P, Harousseau JL, Woronoff-Lemsi MC; Groupe Ouest-Est des Leucémies et des Autres Maladies du Sang. Fagnoni P, et al. Pharmacoeconomics. 2009;27(1):55-68. doi: 10.2165/00019053-200927010-00006. Pharmacoeconomics. 2009. PMID: 19178124

3

[Cost of hospital-based management of acute myeloid leukemia: from analytical to procedure-based tarification].

Fagnoni P, Limat S, Hintzy-Fein E, Martin F, Deconinck E, Cahn JY, Arveux P, Dussaucy A, Woronoff-Lemsi MC. Fagnoni P, et al. Bull Cancer. 2006 Aug;93(8):813-9. Bull Cancer. 2006. PMID: 16935786 Free article. French.

4

[Economic impact of outpatient chemotherapy in multiple myeloma].

Coutet J, Limat S, Voillat L, Deconinck E, Cahn JY, Woronoff-Lemsi MC. Coutet J, et al. Bull Cancer. 2004 Sep;91(9):729-34. Bull Cancer. 2004. PMID: 15544999 Free article. French.

5

Clinical and economic impact of epoetin in adjuvant-chemotherapy for breast cancer.

Fagnoni P, Limat S, Chaigneau L, Guardiola E, Briaud S, Schmitt B, Merrouche Y, Pivot X, Woronoff-Lemsi MC. Fagnoni P, et al. Support Care Cancer. 2006 Oct;14(10):1030-7. doi: 10.1007/s00520-006-0062-5. Epub 2006 Jun 27. Support Care Cancer. 2006. PMID: 16802128

6

Factor XIII replacement in stem-cell transplant recipients with severe hemorrhagic cystitis: a report of four cases.

Demesmay K, Tissot E, Bulabois CE, Bertrand MA, Racadot E, Woronoff-Lemsi MC, Cahn JY, Deconinck E. Demesmay K, et al. Transplantation. 2002 Oct 27;74(8):1190-2. doi: 10.1097/00007890-200210270-00024. Transplantation. 2002. PMID: 12438970

7

From randomised clinical trials to clinical practice : a pragmatic cost-effectiveness analysis of Paclitaxel in first-line therapy for advanced ovarian cancer.

Limat S, Woronoff-Lemsi MC, Menat C, Madroszyk-Flandin A, Merrouche Y. Limat S, et al. Pharmacoeconomics. 2004;22(10):633-41. doi: 10.2165/00019053-200422100-00002. Pharmacoeconomics. 2004. PMID: 15244489

8

Does hospitalisation affect hypnotic and anxiolytic drug prescribing?

Fagnoni P, Limat S, Haffen E, Henon T, Jacquet M, Sechter D, Woronoff-Lemsi MC. Fagnoni P, et al. Pharm World Sci. 2007 Dec;29(6):611-8. doi: 10.1007/s11096-007-9097-z. Epub 2007 Mar 17. Pharm World Sci. 2007. PMID: 17370138

9

[3/3 Steroidal or glucocorticoid anti-inflammatories].

Grangeasse L, Limat S, Woronoff-Lemsi MC. Grangeasse L, et al. Soins. 2007 Apr;(714):59-61. Soins. 2007. PMID: 17533931 French. No abstract available.

10

[1/2 The anti-TNF alpha drugs].

Medjoub M, Limat S, Woronoff-Lemsi MC. Medjoub M, et al. Soins. 2007 Oct;(719):59-61. Soins. 2007. PMID: 18020248 French. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

115 results

Search Page

Filters